By Fiona Craig
Publication Date: 2026-06-11 12:36:00
Nvidia (NASDAQ:NVDA) has entered into a partnership with Abridge to develop a specialised artificial intelligence model tailored for healthcare use cases, according to a report by the Wall Street Journal. Abridge is known for its AI-powered note-taking platform used by medical professionals.
The collaboration reflects growing investment across the technology sector in healthcare-focused AI solutions designed to improve clinical workflows and patient care.
Model to Focus on Clinical Conversations
The companies said the new AI model will be designed specifically around clinical interactions and conversations between healthcare providers and patients.
Rather than being broadly distributed, the model will be deployed exclusively within Abridge’s platform, where it is expected to support a range of healthcare-related tasks including clinical documentation and decision support.
Nvidia is already an investor in Abridge, further strengthening the strategic relationship between the two companies.
Built Using Nvidia’s Nemotron Models
According to Kimberly Powell, Nvidia’s vice president of healthcare, the new healthcare-focused model will be developed using the company’s Nemotron family of open AI models.
Open models are generally made available for users to download, customise and adapt without charge. However, they differ from fully open-source systems…
